The Cooper Cos., Inc. (COO)
69.59
-1.05
(-1.49%)
USD |
NASDAQ |
Sep 04, 16:00
69.58
-0.01
(-0.01%)
After-Hours: 20:00
Cooper Cos. SG&A Expense (TTM) : 1.907B for April 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| April 30, 2026 | 1.907B |
| January 31, 2026 | 1.630B |
| October 31, 2025 | 1.628B |
| July 31, 2025 | 1.60B |
| April 30, 2025 | 1.559B |
| January 31, 2025 | 1.541B |
| October 31, 2024 | 1.534B |
| July 31, 2024 | 1.530B |
| April 30, 2024 | 1.524B |
| January 31, 2024 | 1.551B |
| October 31, 2023 | 1.501B |
| July 31, 2023 | 1.472B |
| April 30, 2023 | 1.439B |
| January 31, 2023 | 1.354B |
| October 31, 2022 | 1.342B |
| July 31, 2022 | 1.296B |
| April 30, 2022 | 1.306B |
| January 31, 2022 | 1.269B |
| October 31, 2021 | 1.211B |
| July 31, 2021 | 1.164B |
| April 30, 2021 | 1.044B |
| January 31, 2021 | 995.40M |
| October 31, 2020 | 992.50M |
| July 31, 2020 | 978.30M |
| April 30, 2020 | 995.30M |
| Date | Value |
|---|---|
| January 31, 2020 | 1.005B |
| October 31, 2019 | 996.60M |
| July 31, 2019 | 995.20M |
| April 30, 2019 | 996.40M |
| January 31, 2019 | 997.50M |
| October 31, 2018 | 973.40M |
| July 31, 2018 | 933.30M |
| April 30, 2018 | 891.00M |
| January 31, 2018 | 836.40M |
| October 31, 2017 | 799.10M |
| July 31, 2017 | 779.73M |
| April 30, 2017 | 753.43M |
| January 31, 2017 | 737.79M |
| October 31, 2016 | 722.79M |
| July 31, 2016 | 713.31M |
| April 30, 2016 | 722.69M |
| January 31, 2016 | 712.61M |
| October 31, 2015 | 712.54M |
| July 31, 2015 | 740.92M |
| April 30, 2015 | 710.34M |
| January 31, 2015 | 698.56M |
| October 31, 2014 | 683.12M |
| July 31, 2014 | 632.34M |
| April 30, 2014 | 623.28M |
| January 31, 2014 | 618.17M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Globus Medical, Inc. | 1.217B |
| West Pharmaceutical Services, Inc. | 426.80M |
| Stryker Corp. | 8.782B |
| Innovative Eyewear, Inc. | 8.608M |
| Abbott Laboratories | 13.94B |